The fact that NCX3 may represent one of the effector of ALS PC is in line with previous works demonstrating that the genetic ablation of this transporter worsens the course of several neurological disorders such as brain ischemia, multiple sclerosis, Alzheimer disease and epilepsy12,13. This evidence concerns the gene SLC8A3 and brain ischemia.